Immediate Impact

61 hit
Sub-graph 1 of 22

Citing Papers

A pan-cancer single-cell panorama of human natural killer cells
2023 Hit
Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial
2022 Hit
3 intermediate papers

Works of Gottfried Doelken being referenced

Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1)
2012
POOR OUTCOME OF TWO CHILDREN WITH RELAPSED STATE STAGE IV ALVEOLAR RHABDOMYOSARCOMA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
2005

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Gottfried Doelken 178 174 77 67 55 15 295
Dubravka Sertić 63 0.4× 110 0.6× 29 0.4× 63 0.9× 74 1.3× 24 286
Karolyn Morris 188 1.1× 119 0.7× 99 1.3× 82 1.2× 32 0.6× 9 258
R. Grace 126 0.7× 68 0.4× 21 0.3× 52 0.8× 52 0.9× 17 350
Gianpaolo Marcacci 192 1.1× 115 0.7× 71 0.9× 129 1.9× 32 0.6× 17 313
Julie Vose 94 0.5× 191 1.1× 13 0.2× 82 1.2× 18 0.3× 20 365
Jagar Jasem 41 0.2× 67 0.4× 24 0.3× 27 0.4× 42 0.8× 16 320
Andrea Heider 140 0.8× 179 1.0× 22 0.3× 106 1.6× 62 1.1× 16 294
T. K. Saikia 153 0.9× 95 0.5× 73 0.9× 45 0.7× 80 1.5× 19 334
Aaron J. Feinstein 57 0.3× 124 0.7× 19 0.2× 18 0.3× 94 1.7× 18 338
Howland E. Crosswell 211 1.2× 181 1.0× 116 1.5× 59 0.9× 36 0.7× 22 336

All Works

Loading papers...

Rankless by CCL
2026